KAUST has signed a worldwide agreement with Thermo Fisher Scientific, granting the company access to two KAUST patents related to high-resolution transmission electron microscopy (HRTEM). The patents enable atomic-resolution TEM imaging of electron beam–sensitive crystalline materials by minimizing beam damage using low doses of electrons. The technology also improves alignment of nano-sized crystals and delivers high signal-to-noise ratio images. Why it matters: This partnership enhances KAUST's role as a global technology university and strengthens Saudi Arabia's position as a hub for scientific advancement in materials science.
KAUST and Thermo Fisher Scientific launched an Electron Microscopy Center of Excellence on May 9. The Center expands the existing partnership between KAUST and Thermo Fisher, focusing on instrument performance and R&D collaboration. It features the FEI Titan Themis Z scanning transmission electron microscope, the first installation globally. Why it matters: The center will provide advanced materials science research capabilities to KAUST researchers, industry partners, and Saudi Arabia, enhancing scientific discovery and technological advancement in the region.
Ahmed Al Saleh, a 2017 KAUST material science and engineering graduate, is now a business development manager at Thermo Fisher Scientific. He is the first Saudi to work for the company, representing them in Saudi Arabia from their KAUST campus office. Al Saleh advises KAUST students to experiment and develop their social skills, embracing failure as part of the learning process. Why it matters: This highlights KAUST's role in developing local talent for key science and technology sectors in Saudi Arabia.
KAUST and FEI (likely referring to FEI Company, now part of Thermo Fisher Scientific) have established a new Center of Excellence. The center will be located at the KAUST Research & Technology Park on the KAUST campus. Why it matters: This partnership enhances KAUST's research capabilities and fosters innovation in science and technology within Saudi Arabia.
KAUST Research Scientist Dr. Ram Karan received a Young Scientist Award at the 15th International Congress on Thermophiles in Japan for his work on extremozymes from Red Sea brine pools. His research focuses on identifying, purifying, and bioengineering microbial proteins from these pools. He utilizes single-amplified genomes (SAGs) to produce extremozyme proteins without needing to grow cells in the lab. Why it matters: This award recognizes KAUST's innovative research into extremophiles, which have the potential to develop novel, sustainable biotechnical processes for industrial applications.
KAUST and the Saudi Food and Drug Authority (SFDA) have partnered to develop a new method using nuclear magnetic resonance (NMR) to detect adulterants in olive oil. The method aims to identify and quantify vegetable oils mixed with olive oil, addressing concerns about the mislabeling of olive oil in the Saudi market. KAUST's comprehensive suite of NMR machines was critical for the project. Why it matters: This collaboration enhances food safety and quality control in Saudi Arabia, a major olive oil importer, and helps to ensure consumers receive authentic, high-quality products.
Jean M. J. Fréchet, retired KAUST senior vice president, has been awarded the King Faisal Prize in Chemistry for his pioneering work in dendrimers, photoresists, and organic photovoltaics. His work has contributed to advancements in biotherapeutics, organic electronics, materials, and microfluidics. Fréchet is the 10th most cited chemist globally, with over 900 publications and 200 patents. Why it matters: The recognition highlights KAUST's impact on global scientific advancement and underscores the importance of investing in basic research with broad applications.
KAUST researchers led by Dr. Niveen Khashab have developed thermosensitive liposomes for controlled drug release, particularly in cancer therapies. The liposomes are designed to release drugs only when they reach heated tumor tissue, minimizing systemic side effects. Cholesterol moieties are used as anchors to create a "nail" or "comb" effect, enabling temperature-triggered drug release inside cells. Why it matters: This targeted drug delivery system could significantly improve the efficacy and reduce the toxicity of cancer treatments.